Epigenetic Regulators in the Development, Maintenance, and Therapeutic Targeting of Acute Myeloid Leukemia
The importance of epigenetic dysregulation to acute myeloid leukemia (AML) pathophysiology has become increasingly apparent in recent years. Epigenetic regulators, including readers, writers, and erasers, are recurrently dysregulated by way of chromosomal translocations, somatic mutations, or genomi...
Main Authors: | Younguk Sun, Bo-Rui Chen, Aniruddha Deshpande |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2018.00041/full |
Similar Items
-
Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects
by: Valentina Gambacorta, et al.
Published: (2019-10-01) -
Targeting histone methyltransferase and demethylase in acute myeloid leukemia therapy
by: Castelli G, et al.
Published: (2017-12-01) -
Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity
by: Samantha L. Goldman, et al.
Published: (2019-03-01) -
Chromatin-Spliceosome Mutations in Acute Myeloid Leukemia
by: Yotaro Ochi, et al.
Published: (2021-03-01) -
Treatment results of pediatric acute myeloid leukemia with epigenetic drugs addition
by: V. S. Nemirovchenko, et al.
Published: (2020-07-01)